Cytosorbents CorporationCTSONASDAQ
Loading
Year-over-year total asset growth rate
Percentile
P46
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -4.67% |
| Q2 2025 | -5.50% |
| Q1 2025 | 7.20% |
| Q4 2024 | -0.90% |
| Q3 2024 | -10.52% |
| Q2 2024 | 13.50% |
| Q1 2024 | -11.62% |
| Q4 2023 | 11.95% |
| Q3 2023 | -9.29% |
| Q2 2023 | -8.73% |
| Q1 2023 | -9.12% |
| Q4 2022 | 1.54% |
| Q3 2022 | -12.55% |
| Q2 2022 | -14.49% |
| Q1 2022 | -6.98% |
| Q4 2021 | -5.84% |
| Q3 2021 | -3.18% |
| Q2 2021 | 12.25% |
| Q1 2021 | -2.75% |
| Q4 2020 | -13.74% |
| Q3 2020 | 111.70% |
| Q2 2020 | 11.38% |
| Q1 2020 | 61.51% |
| Q4 2019 | -4.53% |
| Q3 2019 | 0.70% |
| Q2 2019 | -8.10% |
| Q1 2019 | -5.35% |
| Q4 2018 | -4.39% |
| Q3 2018 | -1.99% |
| Q2 2018 | 23.47% |
| Q1 2018 | 17.43% |
| Q4 2017 | 8.48% |
| Q3 2017 | 0.60% |
| Q2 2017 | 166.45% |
| Q1 2017 | -14.49% |
| Q4 2016 | -10.72% |
| Q3 2016 | -14.58% |
| Q2 2016 | 33.63% |
| Q1 2016 | -15.48% |
| Q4 2015 | -12.09% |